Valuation: FONAR Corporation

Market Cap 125M 108M 102M 93M 174M 12B 175M 1.22B 473M 6.09B 470M 459M 19.4B P/E 2024
10.3x
P/E 2025 11.9x
Enterprise Value 108M 93.19M 88.08M 79.96M 150M 10.32B 151M 1.05B 406M 5.23B 404M 395M 16.68B EV / Sales 2024
0.9x
EV / Sales 2025 0.77x
Free-Float
76.43%
Yield 2024 *
-
Yield 2025 -
1 day-0.10%
6 months+3.86%
Current year+2.86%
Current year 18.3
Extreme 18.3
19.16
1 year 13.9
Extreme 13.9
19.16
3 years 12
Extreme 12
24.05
5 years 12
Extreme 12
24.05
10 years 11
Extreme 11
33.9
Manager TitleAgeSince
Chief Executive Officer 61 11/02/2016
Director of Finance/CFO 71 01/09/2022
Investor Relations Contact - 01/06/1978
Director TitleAgeSince
Chairman 61 07/09/2022
Date Insider Type Main position Quantity % Market Cap. Importance
03/06/26 Other

Chief Executive Officer

0 0%
03/06/26 Other

Chief Financial Officer

0 0%
03/06/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-0.10%-.--%+23.08%+22.77% 125M
+1.25%+7.05%+34.88%+27.71% 237B
+0.17%+2.37%+10.10%-17.37% 147B
+1.72%+8.61%-11.70%+28.67% 133B
+0.56%-1.76%-55.37%-16.66% 63.58B
-1.31%-0.85%-19.46%-15.26% 49.95B
+3.97%+3.70%+19.01%+22.52% 49.42B
+2.74%+6.60%+21.32%+36.93% 42.37B
+1.33%+4.18%+39.15%+54.27% 40.98B
-0.32%+3.82%-16.23%+56.36% 32.82B
Average +1.01%+0.69%+4.48%+19.99% 79.68B
Weighted average by Cap. +1.12%+2.43%+8.31%+16.02%

Financials

2024 2025
Net sales 103M 89.16M 84.27M 76.5M 143M 9.87B 144M 1.01B 389M 5.01B 386M 378M 15.96B 104M 90.43M 85.47M 77.6M 145M 10.01B 146M 1.02B 394M 5.08B 392M 383M 16.18B
Net income 10.57M 9.16M 8.66M 7.86M 14.73M 1.01B 14.82M 103M 39.93M 514M 39.7M 38.82M 1.64B 8.33M 7.22M 6.83M 6.2M 11.62M 800M 11.68M 81.49M 31.49M 406M 31.31M 30.61M 1.29B
Net Debt -14.8M -12.83M -12.12M -11.01M -20.63M -1.42B -20.75M -145M -55.93M -720M -55.6M -54.37M -2.3B -17.54M -15.2M -14.36M -13.04M -24.44M -1.68B -24.59M -171M -66.26M -853M -65.87M -64.41M -2.72B
Logo FONAR Corporation
FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, hiring, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.
Employees
535
  1. Stock Market
  2. Stocks
  3. FONR Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!